By Joe Woelfel and Elsa Ohlen
Stock futures fell Tuesday after President Donald Trump said he had fired Lisa Cook from her job as a Federal Reserve governor, stoking concerns about the central bank's independence.
These stocks were poised to make moves Tuesday:
AT&T rose 0.6% after the telecommunications company said it intended to buy spectrum licenses from EchoStar for $23 billion. AT&T said the purchase would give it the exclusive rights to a slice of the radio frequency spectrum in specific areas. AT&T said the transaction would help it to "maintain long-term leadership in advanced connectivity across 5G and fiber." EchoStar shares jumped 60%.
Interactive Brokers was rising 4.2% after S&P Dow Jones Indices announced the online broker would be replacing Walgreens Boots Alliance in the S&P 500 at the open of trading on Thursday. Walgreens is being acquired by the private-equity firm Sycamore Partners in a deal expected to be completed soon.
Talen Energy jumped 4.3% after the power generator was selected to replace Interactive Brokers in the S&P MidCap 400 index, also beginning Thursday.
Advanced Micro Devices gained 2.1% to $166.81 in premarket trading. Analysts at Truist upgraded the stock to Buy from Hold and raised their price target to $213 from $173. The company may be able to eat into Nvidia's share of the lucrative data-center graphics processing unit market, the analysts said.
Eli Lilly's experimental weight-loss pill orforglipron resulted in up to 10.5% weight-loss in overweight or obese patients with Type 2 diabetes in a late-stage trial. Shares of the pharmaceutical company rose 2.4%.
Palantir Technologies dropped 0.6% ahead of the opening bell. Shares of Palantir, which sells AI software to manage and analyze large amounts of data, declined 1% on Monday. CEO Alex Karp unloaded more than 400,000 shares in the data-analytics company last week, according to a filing with the Securities and Exchange Commission.
Nvidia edged up 0.4% in premarket trading after the maker of chips for artificial-intelligence applications closed up 1% onn Tuesday and extended its streak to two trading sessions. It was the best-performing stock in the Dow Jones Industrial Average on Monday. Coming into Tuesday, Nvidia has risen 34% this year. The chip maker is scheduled to report second-quarter earnings on Wednesday.
Serina Therapeutics soared 31% after the microcap clinical-stage drugmaker said the Food and Drug Administration supported the trial for its experimental treatment for Parkinson's disease. The company said it plans to advance its SER-252 drug under the FDA's new drug application regulatory pathway.
Heico, the maker of aerospace aftermarket parts, reported fiscal third-quarter earnings of $1.26 a share, better than analysts' estimates of $1.13. Revenue of $1.15 billion topped forecasts of $1.12 billion. The stock was up 1.5%.
Semiconductor company Semtech posted second-quarter adjusted earnings of 41 cents a share, beating analysts' estimates by 1 cent, as revenue of $258 million rose 20% from a year earlier and topped consensus. Semtech said it expects third-quarter adjusted earnings of 44 cents a share, plus or minus 3 cents, in line with estimates. Shares rose 3%.
Earnings reports are expected Tuesday from MongoDB, Okta, Box, nCino, and PVH.
Write to Joe Woelfel at joseph.woelfel@barrons.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
August 26, 2025 07:37 ET (11:37 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.